Minnesota 2025-2026 Regular Session

Minnesota Senate Bill SF1729

Introduced
2/20/25  

Caption

Provisions modification regarding the sale of cannabinoids derived from hemp

Impact

The bill mandates that the sale of edible cannabinoid products is tightly regulated, requiring manufacturers to convert their existing registrations into comparable hemp licenses. Additionally, the bill modifies existing provisions for hemp-derived topical products and enforces compliance with state and local building, fire, and zoning codes. This regulation aims to promote safe practices amongst manufacturers and retailers, reducing the risk of health implications associated with hemp products while aligning state law with emerging market trends in cannabinoid consumption.

Summary

S.F. No. 1729, a bill introduced in the Minnesota legislature, addresses the regulation of cannabinoids derived from hemp, particularly focusing on the sale and consumption of edible cannabinoid products. The legislation stipulates that any product containing nonintoxicating cannabinoids must not exceed certain concentrations of tetrahydrocannabinol (THC) when sold for human or animal consumption. It highlights that products meant for human consumption should not contain more than 0.3% THC, adhering to federal guidelines and ensuring they are not marketed for their psychoactive effects.

Contention

Discussions surrounding SF1729 may reveal contention regarding public health and safety concerns. On one side, proponents of the bill advocate for strict regulations to prevent misuse and protect consumers, particularly minors, by prohibiting the sale of such products to individuals younger than 21 years. Conversely, opponents may argue that stringent regulations could limit access to beneficial hemp-derived products, particularly given the rising interest in cannabinoids for health and wellness. Local manufacturers may also express concern regarding the complexity and financial burden of compliance with the new regulations.

Notable_points

While SF1729 does not directly address the therapeutic claims of hemp products, it establishes a clear framework for product labeling and safety. This includes enforcing that labels provide comprehensive information about the manufacturer's details, laboratory testing, and cannabinoid content, thereby promoting consumer awareness. The bill's emphasis on compliance with health standards illustrates a commitment to safeguarding public health while attempting to foster a burgeoning industry focused on hemp-derived products.

Companion Bills

MN HF1271

Similar To Provisions regarding the sale of cannabinoids derived from hemp modified, person selling edible cannabinoids permitted to convert the person's registration to a comparable hemp license, and hemp-derived topical product provisions modified.

Previously Filed As

MN HF1271

Provisions regarding the sale of cannabinoids derived from hemp modified, person selling edible cannabinoids permitted to convert the person's registration to a comparable hemp license, and hemp-derived topical product provisions modified.

MN S0137

Hemp-Derived Cannabinoids

MN SF2172

Various cannabis provisions modifications

MN SF4403

Cannabis business licensing provisions technical changes

MN HF4199

Technical changes made to cannabis business licensing provisions.

MN SF556

Cannabis selling and advertising provisions modifications

MN SF4429

Cannabis business and hemp business license provisions modification

MN HF1254

Manufacture of certain products for sale outside of Minnesota provided, tetrahydrocannabivarin designated as a nonintoxicating cannabinoid, potency limits modified, social equity ownership requirements lowered to 51 percent, manufacturing limits established, and cannabis cultivator license authorizations clarified.

MN SB682

Regulating hemp-derived cannabinoid products.

MN AB747

Regulating hemp-derived cannabinoid products.

Similar Bills

OR SB1548

Relating to marijuana; prescribing an effective date.

UT HB0469

Cannabinoid Amendments

UT HB0054

Cannabinoid Amendments

SC S0137

Hemp-Derived Cannabinoids

SC H3601

Hemp Derived Canabis

AL SB255

Cannabinoid products from hemp; sale regulated by Revenue Department, licensure required; tax imposed

PA HB2309

In preliminary provisions, further providing for definitions; in Pennsylvania Liquor Control Board, further provid ing for general powers of board, for restrictions on members of the board and certain employees of Commonwealth, for enforcement and for biennial reports; in licenses and regulations, liquor, alcohol and malt and brewed beverages, further providing for malt and brewed beverages manufacturers', distributors' and importing distributors' licenses, for number and kinds of licenses allowed same licensee, for responsible alcohol management, for surrender of restaurant, eating place retail dispenser, hotel, club, catering club, importing distributor and distributor license for benefit of licensee, for unlawful acts relative to malt or brewed beverages and licensees and for liability of licensees; providing for hemp-derived cannabinoid beverages; establishing the Local Hemp Sharing Fund; and imposing penalties.

MN HF1615

Cannabis policy bill.